Articles

Poll

Podcasts

Slideshows

Videos

Endocrinology

The HCPLive endocrinology page is a comprehensive resource for clinical news and insights on endocrine system conditions. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for diabetes, hormonal disease, and more.

The FDA has greenlit Dexcom's Stelo Glucose Biosensor System, marking a historic first as the first continuous glucose monitors to be available over-the-counter.

FDA Clears Dexcom Stelo Sensor, First OTC Glucose Sensor in Agency History

Hosts breakdown a pair of recent publications related to better understanding the strengths and limitations of MARD as well as a study comparing the Dexcom G7 and FreeStyle Libre 3 sensors.

Diabetes Dialogue: Understanding MARD, Comparing Popular CGM Sensors

Hosts break down their favorite sessions at the upcoming 17th International Conference on Advanced Technologies and Treatments for Diabetes. 

Diabetes Dialogue: ATTD 2024 Preview

Viral Shah, MD, joins Diabetes Dialogue to discuss a recent study examining associations between time in range and other advanced CGM metrics with diabetic retinopathy and the implications for use in predicting other microvascular outcomes. 

Diabetes Dialogue: Time in Range, CGM Metrics for Predicting Outcomes in Diabetes

Viral Shah, MD, of Indiana University, joins Diabetes Dialogue to discuss a recent proof-of-concept study examining use of tirzepatide in type 1 diabetes. 

Diabetes Dialogue: Tirzepatide in Type 1 Diabetes, with Viral Shah, MD

A new study found balance and falling were linked to an increased risk of all-cause mortality, as well as cause-specific mortality from cardiovascular disease and diabetes.


Dizziness Linked to Mortality Risk for Diabetes, Cardiovascular Disease, Cancer

A new proof-of-concept observation study reports the dual GLP-1/GIP agonist's positive efficacy and safety for adults with T1D.

Tirzepatide Significantly Reduces HbA1c, Body Weight in Type 1 Diabetes 

This endocrinology month in review spotlights FDA news, a pair of studies examining cardiovascular and renal risk reduction in type 2 diabetes, results from a subtrial examining testosterone’s effect on fracture risk, and 4 new episodes of diabetes dialgoue

Endocrinology Month in Review: January 2024

In this episode, hosts discuss recent news and updates in diabetes technology from Abbott, Dexcom, and Medtronic in the first half of January 2024.

Diabetes Dialogue: Diabetes Technology Updates in January 2024

A study of more than 140 adults with diabetes is providing additional insight into the prevalence of anemia among these patients as well as its association with changes in glycemic control. 